Stopping cancer growth
Ontario scientist develops anti-cancer therapy
An Ontario scientist has developed the first cancer therapy to inhibit an aggressive form of leukemia by targeting a protein, CD123, that is on the surface of cancer stem cells, which are responsible for cancer growth. Dr. John Dick, a senior scientist at the Ontario Institute for Cancer Research, is working on clinical trials with other researchers in Australia. The head of OICR suggests that this discovery could help treat other types of tumors too. This is exciting because cancer stem cells are what can lead to a recurrence of the disease. Targeting them may prevent that devastating possibility.
Related Posts
Life
Debating the pros and cons of Daylight Saving Time
Ahead of the end of this year’s daylight saving on Nov. 7, Shannon Proudfoot breaks down the pros and cons of the increasingly unpopular practice
General
Maclean’s 2022 Student Survey Contest Rules
CONTEST RULES (the “Official Rules”) Maclean’s Student Survey 2022 Contest (the “Contest”) WHO ARE THE SPONSORS?...
General
Maclean’s Registration wall FAQ
You can read five Macleans.ca articles every 30 days. To read more, you must create an account or log in to an existing...
Get the Best of Maclean’s straight to your inbox.
Sign up for news, commentary and analysis. Join 60,000+ Canadian readers.